When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GEMP - Gemphire down 6% on uneven results from POC study of gemcabene
Gemphire Therapeutics Inc.
Thinly traded nano cap Gemphire Therapeutics (NASDAQ:GEMP) is down 6% premarket in reaction to results from five-subject open-label proof-of-concept (POC) study evaluating gemcabene in patients with a rare inherited fatty tissue disorder called familial partial lipodystrophy (FPLD).
More news on: Gemphire Therapeutics Inc., Healthcare stocks news, Stocks on the move,